Voloridge Investment Management
MLAB icon

Voloridge Investment Management’s Mesa Laboratories MLAB Stock Holding History

Voloridge Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,853
Closed -$300K – 1351
2023
Q3 		$300K Sell
2,853
-1,449
-34% -$186K ﹤0.01% 1282
2023
Q2 		$553K Buy
+4,302
New +$656K ﹤0.01% 1216
2020
Q1 		– Sell
-910
Closed -$227K – 1280
2019
Q4 		$227K Buy
+910
New +$213K ﹤0.01% 978

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Voloridge Investment Management's MLAB Position: Q4 2023 in Review

Voloridge Investment Management sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 2,853 shares — an estimated $300K sold.

Voloridge Investment Management first reported a position in MLAB in Q4 2019 and held it in 3 quarters. The position peaked at $553K in Q2 2023. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.

  • Voloridge Investment Management reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 2,853 Mesa Laboratories shares in Q4 2023, an estimated $300K.
  • Voloridge Investment Management first reported a position in Mesa Laboratories in Q4 2019 and held it in 3 quarters.
  • Voloridge Investment Management's Mesa Laboratories position peaked at $553K in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.